Lupin shares also closed at their all-time high after the drugmaker's quarterly results beat expectations, while hopes for continued foreign inflows also lifted index heavyweights such as cigarette maker ITC.
Although foreign portfolio investors have so far bought $12.34 billion of Indian stocks in 2013, the outlook still remains robust amid global shares rising to new five-year highs.
Still, traders said the near-term outlook for markets would depend on the outcome of the election in Karnataka and the Supreme Court decision on accusations the law minister interfered with Central Bureau of Investigation (CBI) probe into irregularities in the award of coal field concessions.
Both issues have raised fears about political instability, although a resounding victory from Congress party in Karnataka would help soothe those concerns. "Hot money, liquidity will continue to drive markets amid potential challenges coming from Karnataka polls and the Supreme Court's verdict," said Deven Choksey, managing director at KR Choksey Securities.
The Sensex rose 0.51 per cent, or 101.23 points, to end at 19,990.18, marking its highest close since January 30.
The broader Nifty rose 0.43 per cent, or 25.75 points, to end at 6,069.30, closing above the psychologically important 6,000 level for the second day and its highest close since January 28.
Broad-based buying on expectations of strong foreign inflows lifted index heavyweights such as ITC Ltd, which rose 2.2 per cent, while Reliance Industries ended 0.2 per cent higher.
HDFC, India's biggest mortgage lender, rose 3.7 per cent, closing at its all-time high, after it reported a 17.3 percent rise in net profit for the Jan-March quarter.
Lupin shares also gained 2.2 percent to scale an all-time high after the company said quarterly net profit more than doubled to 4.08 billion rupees.
Shares in Corporation Bank(CRBK.NS: Quote, Profile, Research) gained 6.6 percent after it said non-performing loans as a percentage of total assets were at 1.19 percent in the March quarter, down from 1.63 percent in the December quarter.
Corporation Bank's quarterly net profit beat expectations, helped by lower provisions.
Glenmark Pharmaceuticals (GLEN.NS: Quote, Profile, Research) shares rose 1 percent after it posted a quarterly profit rise by 11.3 percent to 1.67 billion rupees.
However, Ranbaxy Laboratories (RANB.NS: Quote, Profile, Research) shares lost 2.6 percent after it reported a 90 percent drop in first quarter net profit compared with a year earlier.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)